The aim of this study was to evaluate if patients with prior myocardial infarction (MI) could benefit from ticagrelor monotherapy in terms of bleeding reduction without any compromise in ischemic event prevention.

Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy

Chiarito, Mauro;Cao, Davide;Stefanini, Giulio;
2022

Abstract

The aim of this study was to evaluate if patients with prior myocardial infarction (MI) could benefit from ticagrelor monotherapy in terms of bleeding reduction without any compromise in ischemic event prevention.
aspirin
drug-eluting stent(s)
percutaneous coronary intervention
prior myocardial infarction
ticagrelor
Drug Therapy, Combination
Humans
Platelet Aggregation Inhibitors
Ticagrelor
Treatment Outcome
Drug-Eluting Stents
Myocardial Infarction
Percutaneous Coronary Intervention
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/69679
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact